0001209191-19-043395.txt : 20190726 0001209191-19-043395.hdr.sgml : 20190726 20190726172630 ACCESSION NUMBER: 0001209191-19-043395 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190613 FILED AS OF DATE: 20190726 DATE AS OF CHANGE: 20190726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galante Joseph C CENTRAL INDEX KEY: 0001632384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 19978761 MAIL ADDRESS: STREET 1: 111 TENTH AVENUE STREET 2: SUITE 200 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-13 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001632384 Galante Joseph C 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2019-06-13 4 P 0 60 6.42 A 11618 D Common Stock 2019-06-14 4 P 0 60 6.37 A 11678 D Common Stock 2019-06-17 4 P 0 60 6.33 A 11738 D Common Stock 2019-06-18 4 P 0 60 6.36 A 11798 D Common Stock 2019-06-19 4 P 0 60 6.35 A 11858 D Common Stock 2019-06-20 4 P 0 60 6.33 A 11918 D Common Stock 2019-06-21 4 P 0 60 6.34 A 11978 D Common Stock 2019-06-24 4 P 0 60 6.54 A 12038 D Common Stock 2019-06-25 4 P 0 60 6.56 A 12098 D Common Stock 2019-06-26 4 P 0 60 6.54 A 12158 D Common Stock 2019-06-27 4 P 0 60 6.48 A 12218 D Common Stock 2019-06-28 4 P 0 60 6.49 A 12278 D Common Stock 2019-07-01 4 P 0 60 6.52 A 12338 D Common Stock 2019-07-02 4 P 0 60 6.49 A 12398 D Common Stock 2019-07-03 4 P 0 60 6.46 A 12458 D Common Stock 2019-07-05 4 P 0 60 6.49 A 12518 D Common Stock 2019-07-08 4 P 0 60 6.37 A 12578 D Common Stock 2019-07-09 4 P 0 60 6.15 A 12638 D Common Stock 2019-07-10 4 P 0 60 6.07 A 12698 D Common Stock 2019-07-11 4 P 0 60 5.93 A 12758 D Common Stock 2019-07-12 4 P 0 60 6.01 A 12818 D Common Stock 2019-07-15 4 P 0 60 5.85 A 12878 D Common Stock 2019-07-16 4 P 0 60 5.88 A 12938 D Common Stock 2019-07-17 4 P 0 60 5.85 A 12998 D Common Stock 2019-07-18 4 P 0 60 5.84 A 13058 D Common Stock 2019-07-19 4 P 0 60 5.69 A 13118 D Common Stock 2019-07-22 4 P 0 60 5.75 A 13178 D Common Stock 2019-07-24 4 P 0 60 5.93 A 13238 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Joseph C. Galante by /s/ Michael Bonner as attorney-in-fact 2019-07-26